192 related articles for article (PubMed ID: 34315816)
1. SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication.
Shkreta L; Delannoy A; Salvetti A; Chabot B
RNA; 2021 Nov; 27(11):1302-1317. PubMed ID: 34315816
[TBL] [Abstract][Full Text] [Related]
2. Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.
Blázquez-Encinas R; García-Vioque V; Caro-Cuenca T; Moreno-Montilla MT; Mangili F; Alors-Pérez E; Ventura S; Herrera-Martínez AD; Moreno-Casado P; Calzado MA; Salvatierra Á; Gálvez-Moreno MA; Fernandez-Cuesta L; Foll M; Luque RM; Alcala N; Pedraza-Arevalo S; Ibáñez-Costa A; Castaño JP
J Transl Med; 2023 Dec; 21(1):879. PubMed ID: 38049848
[TBL] [Abstract][Full Text] [Related]
3. SRSF10 facilitates HCC growth and metastasis by suppressing CD8
Luo X; Zhang Z; Li S; Wang Y; Sun M; Hu D; Jiang J; Wang Y; Ji X; Chen X; Zhang B; Liang H; Li Y; Liu B; Xu X; Wang S; Xu S; Nie Y; Wu K; Fan D; Liu D; Huang W; Xia L
Int Immunopharmacol; 2024 Jan; 127():111376. PubMed ID: 38113691
[TBL] [Abstract][Full Text] [Related]
4. Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for glioma.
An W; Yang Q; Xi Y; Pan H; Huang H; Chen Q; Wang Y; Hua D; Shi C; Wang Q; Sun C; Luo W; Li X; Yu S; Zhou X
Life Sci; 2024 Feb; 338():122392. PubMed ID: 38160788
[TBL] [Abstract][Full Text] [Related]
5. SR proteins in cancer: function, regulation, and small inhibitor.
Bei M; Xu J
Cell Mol Biol Lett; 2024 May; 29(1):78. PubMed ID: 38778254
[TBL] [Abstract][Full Text] [Related]
6. Serine-arginine protein kinases and their targets in viral infection and their inhibition.
Zheng K; Ren Z; Wang Y
Cell Mol Life Sci; 2023 May; 80(6):153. PubMed ID: 37198350
[TBL] [Abstract][Full Text] [Related]
7. Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer.
Zheng X; Peng Q; Wang L; Zhang X; Huang L; Wang J; Qin Z
Int J Biol Sci; 2020; 16(13):2442-2453. PubMed ID: 32760211
[TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics and clinical implications of serine/arginine-rich splicing factors in human cancer.
Zhang J; Fang Z; Song C
Aging (Albany NY); 2023 Nov; 15(22):13287-13311. PubMed ID: 38015716
[TBL] [Abstract][Full Text] [Related]
9. SRSF2 mutation cooperates with ASXL1 truncated alteration to accelerate leukemogenesis.
Sui P; Ge G; Chen S; Bai J; Rubalcava IP; Yang H; Guo Y; Zhang P; Li Y; Medina EA; Xu M; Abdel-Wahab O; Bradley R; Yang FC
Leukemia; 2024 Feb; 38(2):408-411. PubMed ID: 38017104
[No Abstract] [Full Text] [Related]
10. A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells.
Sohail M; Shkreta L; Toutant J; Rabea S; Babeu JP; Huard C; Coulombe-Huntington J; Delannoy A; Placet M; Geha S; Gendron FP; Boudreau F; Tyers M; Grierson DS; Chabot B
NAR Cancer; 2021 Jun; 3(2):zcab019. PubMed ID: 34316707
[TBL] [Abstract][Full Text] [Related]
11. Cytokine receptor DOME controls wing disc development in Bombyx mori.
Wang Y; Zhou L; Liang W; Dang Z; Wang S; Zhang Y; Zhao P; Lu Z
Insect Biochem Mol Biol; 2022 Sep; 148():103828. PubMed ID: 36002096
[TBL] [Abstract][Full Text] [Related]
12. RNA splicing dysregulation and the hallmarks of cancer.
Bradley RK; Anczuków O
Nat Rev Cancer; 2023 Mar; 23(3):135-155. PubMed ID: 36627445
[TBL] [Abstract][Full Text] [Related]
13. SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis.
Liu X; Zheng Y; Xiao M; Chen X; Zhu Y; Xu C; Wang F; Liu Z; Cao K
J Exp Clin Cancer Res; 2022 Dec; 41(1):353. PubMed ID: 36539837
[TBL] [Abstract][Full Text] [Related]
14. SRSF10 is essential for progenitor spermatogonia expansion by regulating alternative splicing.
Liu W; Lu X; Zhao ZH; Su R; Li QL; Xue Y; Gao Z; Sun SS; Lei WL; Li L; An G; Liu H; Han Z; Ouyang YC; Hou Y; Wang ZB; Sun QY; Liu J
Elife; 2022 Nov; 11():. PubMed ID: 36355419
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing as a source of phenotypic diversity.
Wright CJ; Smith CWJ; Jiggins CD
Nat Rev Genet; 2022 Nov; 23(11):697-710. PubMed ID: 35821097
[TBL] [Abstract][Full Text] [Related]
16. Sonic hedgehog signaling: Alternative splicing and pathogenic role in medulloblastoma.
Qu M; He Q; Luo J; Shen T; Gao R; Xu Y; Xu C; Barkat MQ; Zeng LH; Wu X
Genes Dis; 2023 Sep; 10(5):2013-2028. PubMed ID: 37492706
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and therapeutic potential of circular RNA in brain tumors.
Katsushima K; Joshi K; Perera RJ
Neurooncol Adv; 2023; 5(1):vdad063. PubMed ID: 37334165
[TBL] [Abstract][Full Text] [Related]
18. HNRNPH1 regulates the neuroprotective cold-shock protein RBM3 expression through poison exon exclusion.
Lin JQ; Khuperkar D; Pavlou S; Makarchuk S; Patikas N; Lee FC; Zbiegly JM; Kang J; Field SF; Bailey DM; Freeman JL; Ule J; Metzakopian E; Ruepp MD; Mallucci GR
EMBO J; 2023 Jul; 42(14):e113168. PubMed ID: 37248947
[TBL] [Abstract][Full Text] [Related]
19. Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases.
Song M; Pang L; Zhang M; Qu Y; Laster KV; Dong Z
Signal Transduct Target Ther; 2023 Apr; 8(1):148. PubMed ID: 37029108
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
